Press release
Investigation announced for Long-Term Investors in NASDAQ: ACRX shares) over potential Wrongdoing at AcelRx Pharmaceuticals, Inc
An investigation on behalf of current long term investors in AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares.
Investors who are current long term investors in AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ACRX stocks follows a lawsuit filed against AcelRx Pharmaceuticals, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ACRX stocks, concerns whether certain AcelRx Pharmaceuticals, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that: AcelRx had deficient disclosure controls and procedures with respect to its marketing of DSUVIA, that as a result, AcelRx had been making false or misleading claims and representations about the risks and efficacy of DSUVIA in certain advertisements and displays, that the foregoing conduct subjected the Company to increased regulatory scrutiny and enforcement, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) have certain options and should contact the Shareholders Foundation. Contact: Shareholders Foundation, Inc.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in NASDAQ: ACRX shares) over potential Wrongdoing at AcelRx Pharmaceuticals, Inc here
News-ID: 2399865 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for AcelRx
Ubiquitin Enzymes Market Growth in Future Scope 2022-2028 | 3SBio, 5AM Ventures, …
Ubiquitin Enzymes Market Research focuses on the key trends prevailing in the Global Ubiquitin Enzymes Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report comprises evaluation of numerous influential factors including industry overview in terms of historic and present situation, key manufacturers, product/service application and types, key regions and marketplaces, forecast estimation for global…
Deadline coming up on August 9th in Lawsuit for Investors in AcelRx Pharmaceutic …
A deadline is coming up on August 9, 2021 in the lawsuit filed for certain investors of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) over alleged securities laws violations by AcelRx Pharmaceuticals, Inc.
Investors who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) have certain options and there are strict and short deadlines running. Deadline: August 9, 2021. NASDAQ: ACRX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors in shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: A …
An investor, who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), filed a lawsuit over alleged violations of Federal Securities Laws by AcelRx Pharmaceuticals, Inc.
Investors who purchased shares of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 9, 2021. NASDAQ: ACRX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Redwood City, CA based…
Hematuria Treatment Market 2028 Analysis of Key Players – Neurocrine Bioscienc …
A new market report by The Insight Partners on the Hematuria Treatment Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have…
Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era | …
The research report on Pain Management Market provides a comprehensive analysis of the market status and development trend, including types, applications, growth, opportunities, rising technology, competitive landscape and product offerings of key players. Pain Management Market report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period.
Rescheduling of Hydrocodone combinations from Class III to Class II, clear-cut…
Ubiquitin Enzymes Market – In-Depth Qualitative Insights and Growth Analysis W …
Ubiquitin enzymes, is also termed by E2 enzyme and seldom as known ubiquitin-carrier enzymes. This helps to achieve the second successive step in the ubiquitination process that aims at a protein to cut into various segments through the proteasome. The ubiquitination process firmly attaches ubiquitin, which is a short protein consisting of 76 amino acids, to a lysine deposit on the essential protein to be targeted. Once a protein gets…
